|
Volumn 61, Issue 1, 2014, Pages 170-171
|
Reply to: Anti-TNF-induced autoimmune hepatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
AUTOANTIBODY;
AUTOANTIGEN;
BACTERIAL ANTIGEN;
CARDIOLIPIN ANTIBODY;
CD86 ANTIGEN;
CERTOLIZUMAB PEGOL;
CYTOKINE;
ETANERCEPT;
GAMMA INTERFERON;
GLUCOCORTICOID;
GOLIMUMAB;
HLA DRB1 ANTIGEN;
INFLIXIMAB;
INTERLEUKIN 10;
LIVER ENZYME;
TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR ANTIBODY;
MONOCLONAL ANTIBODY;
TUMOR NECROSIS FACTOR ALPHA;
ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD;
ANTIGEN EXPRESSION;
APOPTOSIS;
ARTHRITIS;
AUTOIMMUNE HEPATITIS;
B LYMPHOCYTE ACTIVATION;
BACTERIAL INFECTION;
CPG ISLAND;
CYTOKINE PRODUCTION;
DISEASE ASSOCIATION;
DISEASE EXACERBATION;
DOWN REGULATION;
DRUG BINDING;
DRUG MECHANISM;
DRUG SAFETY;
GENETIC PREDISPOSITION;
GENETIC SUSCEPTIBILITY;
HORMONE SYNTHESIS;
HUMAN;
IMMUNE RESPONSE;
IMMUNOTHERAPY;
INFLAMMATORY BOWEL DISEASE;
LETTER;
LIVER BIOPSY;
LUPUS LIKE SYNDROME;
NATURAL KILLER CELL;
NUCLEOLUS;
OFF LABEL DRUG USE;
PATIENT SELECTION;
PRIORITY JOURNAL;
PSORIASIS;
RISK FACTOR;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TH1 CELL;
TH2 CELL;
UPREGULATION;
UVEITIS;
VASCULITIS;
ANTAGONISTS AND INHIBITORS;
FEMALE;
HEPATITIS, AUTOIMMUNE;
MALE;
ANTIBODIES, MONOCLONAL;
FEMALE;
HEPATITIS, AUTOIMMUNE;
HUMANS;
MALE;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 84902679600
PISSN: 01688278
EISSN: 16000641
Source Type: Journal
DOI: 10.1016/j.jhep.2014.03.008 Document Type: Letter |
Times cited : (1)
|
References (10)
|